Atovaquone
- Product NDC
- 50268-086
- 11-digit product format
- 502680086
- Labeler code
- 50268
- Product ID
- 50268-086_10fc4532-0b9f-4511-b0a2-bd7edd49cb47
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atovaquone
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA210692
- Marketing category
- ANDA
- Marketing start
- 2020-05-07
- Marketing end
- 0000-00-00
- Substance
- ATOVAQUONE
- Active strength
- 750 mg/5mL
- Pharmacologic classes
- Antimalarial [EPC], Antiprotozoal [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-086 | ATOVAQUONE SUSPENSION [AVPAK] | 3 | Legacy NDC | 20240110_a50fb7df-6f2d-63f9-e053-2a95a90ad9d3.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-086-12 | 50268008612 | 20 CUP, UNIT-DOSE in 1 BOX (50268-086-12) > 5 mL in 1 CUP, UNIT-DOSE (50268-086-11) | 2020-05-07 | 0000-00-00 | No | No | Current |